November 18, 2022

Katherine Rundell’s Super-Infinite: The Transformations of John Donne Wins the Baillie Gifford Prize for Non-Fiction 2022

Super-Infinite: The Transformations of John Donne by Katherine Rundell

LONDON, Nov. 17, 2022 (GLOBE NEWSWIRE) — Super-Infinite: The Transformations of John Donne by Katherine Rundell has been named winner of the Baillie Gifford Prize for Non-Fiction 2022. The winner was announced by Chair of Judges Caroline Sanderson at a ceremony hosted at the Science Museum and generously supported by The Blavatnik Family Foundation. The announcement was streamed to readers around the world via the Baillie Gifford Prize social media channels.

Super-Infinite: The Transformations of John Donne gives readers a window into the little-known myriad lives the poet John Donne lived. He was a scholar of law, a maritime adventurer, an MP, a priest, the Dean of St Paul’s Cathedral – and perhaps the greatest love poet in the history of the English language. Standout scholar Katherine Rundell shows readers the many sides of his life, his obsessions, his blazing words, and his tempestuous Elizabethan times – unveiling Donne as the most remarkable mind and as a lesson in living.

Katherine Rundell is a Fellow of All Souls College, Oxford, where she works on Renaissance literature. Her bestselling books for children have been translated into more than 30 languages and have won multiple awards. Rundell is also the author of a book for adults, Why You Should Read Children’s Books, Even Though You Are So Old and Wise. She has written for, among others, the London Review of Books, the Times Literary Supplement, the New York Review of Books and The New York Times, largely about books, though sometimes about animals, night climbing and tightrope walking.

The Baillie Gifford Prize aims to recognise and reward the best of non-fiction and is open to authors of any nationality. It covers all non-fiction in the areas of current affairs, history, politics, science, sport, travel, biography, autobiography and the arts. As the winner, Rundell will receive £50,000 along with the £1,000 given to each of the shortlisted authors. Last year’s winner was Patrick Radden Keefe for Empire of Pain, which became a Sunday Times bestseller.

Super-Infinite: The Transformations of John Donne was chosen by this year’s judging panel: writer and Associate Editor of The Bookseller, Caroline Sanderson (chair); writer and science journalist, Laura Spinney; critic and writer for The Observer, Rachel Cooke; BBC journalist and presenter, Clive Myrie; author and New Yorker writer, Samanth Subramanian; and critic and broadcaster, Georgina Godwin. Their selection was made from 362 books published between 1 Nov. 2021 and 31 Oct. 2022.

The other titles on this year’s shortlist were:

Author / translator (Nationality)	Title (Imprint)
Caroline Elkins (American)	Legacy of Violence: A History of the British Empire (The Bodley Head, Vintage, Penguin Random House UK)
Jonathan Freedland (British)	The Escape Artist: The Man Who Broke Out of Auschwitz to Warn the World (John Murray Press, Hachette)
Sally Hayden (Irish)	My Fourth Time, We Drowned: Seeking Refuge on the World’s Deadliest Migration Route (4th Estate, HarperCollins)
Anna Keay (British)	The Restless Republic: Britain Without a Crown (William Collins, Harper Collins)
Polly Morland (British)	A Fortunate Woman: A Country Doctor’s Story (Picador, Pan Macmillan)

READ SMART, the Baillie Gifford Prize for Non-Fiction’s podcast, will release an episode devoted to the winner of the 2022 award, hosted by Razia Iqbal and featuring Katherine Rundell. It will be available on Thursday, 24 Nov.

-ENDS-

For information about the prize, visit: www.thebailliegiffordprize.co.uk

or follow us on Twitter @BGPrize #BGPrize2022

For more information about Super-Infinite: The Transformations of John Donne, Katherine Rundell, Baillie Gifford or the Blavatnik Family Foundation, please click the following link: https://we.tl/t-e6e9hF28tq

Images of the winning author and book are available to download here.

This folder is being updated with images from the ceremony.

Contact Information:
Nathaniel Ashley
Account Executive
nathaniel.ashley@fourcommunications.com
+44 (0)20 3103 9598

Julie Holman
Account Director
julie.holman@fourcommunications.com
+44 (0)7841 672 393

Super-Infinite: The Transformations of John Donne by Katherine Rundell

This content was issued through the press release distribution service at Newswire.com.

Attachment

Super-Infinite: The Transformations of John Donne by Katherine Rundell

GlobeNewswire Distribution ID 8699308

November 18, 2022

Nyxoah to Participate in the Piper Sandler 34th Annual Healthcare Conference

Nyxoah to Participate in the Piper Sandler 34^th Annual Healthcare Conference

Mont-Saint-Guibert, Belgium – November 17, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Piper Sandler 34^th Annual Healthcare Conference, which takes place November 29-December 1, 2022, at the Lotte New York Palace hotel in New York.

Olivier Taelman, Nyxoah’s Chief Executive Officer, will deliver a corporate update during a fireside chat on Thursday, December 1, 2022, at 12:00pm ET. A webcast of the presentation will be available on the Events section of Nyxoah’s Investor Relations website. The Company will also be available for 1×1 meetings with institutional investors attending the event.

Nyxoah’s updated Investor Presentation can be accessed on the Shareholder Information section of the Company’s Investor Relations page.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and US commercialization approval.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Contacts:
Nyxoah
Loic Moreau, Chief Financial Officer
corporate@nyxoah.com
+32 473 33 19 80

Jeremy Feffer, VP IR and Corporate Communications
jeremy.feffer@nyxoah.com
+1 917 749 1494

Attachment

ENGLISH_Piper Sandler Conference PR_FINAL

GlobeNewswire Distribution ID 1000757427

November 18, 2022

TJP Labs Inc. Amends Its Drug Establishment License and Achieves Approval for Active Pharmaceutical Ingredients

PICKERING, Ontario, Nov. 17, 2022 (GLOBE NEWSWIRE) — TJP Labs Inc. (“TJP Labs”) is North America’s leading full-service contract manufacturer of premier next-generation products, focusing on modern oral nicotine pouches and oral delivery solutions for caffeine and other nutraceutical products. Today, TJP Labs announced that after completing a thorough regulatory assessment and meeting all GMP requirements, it received a notice of compliance for Active Pharmaceutical Ingredients (API) following an audit by the Health Canada Drug GMP Inspection Program.

The announcement aligns with TJP Labs’ strategy to offer drug manufacturing services, and the new achievement enables TJP Labs to spearhead further licensable activities.

Speaking on the achievement, David Richmond-Peck, CEO of TJP Labs, remarked:

“I cannot overstate the significance of this most recent compliant rating by Health Canada, and I congratulate our quality and manufacturing teams on their continued success.

GMP certification for Active Pharmaceutical Ingredients accelerates TJP’s bold innovation strategy in the modern oral and beyond nicotine categories. Furthermore, it reinforces that our facilities operate to a set of internationally recognized pharmaceutical standards to ensure product quality and safety.

The modern oral category is seeing exponential growth and this critical API milestone positions TJP as a formidable and aggressive partner. There is a growing demand for innovation, and our certifications give us the unique ability to provide more value-added products and services. But, most importantly, it allows us to offer a broad range of best-in-class products across multiple categories. It also enhances TJP’s long-term value for our investors.”

About TJP Labs Inc.
TJP Labs is a leading North American full-service manufacturer of premium quality next-generation products, specializing in modern oral nicotine, energy, and nutraceutical pouches. Our products are manufactured and packaged in our DEL, Site-Licensed, cGMP/HACCP compliant, ISO 9001:2015 certified state-of-the-art facilities.

Contacts

David Richmond-Peck – business@tjplabs.com

Website: www.tjplabs.com

GlobeNewswire Distribution ID 8699638

November 18, 2022

Foreign detainees arrive home after Myanmar prisoner amnesty

Australian economist Sean Turnell and Japanese journalist Toru Kubota arrived home Friday after an amnesty by the Myanmar junta for thousands of prisoners including four foreign nationals arrested since a military coup that has thrust the Southeast Asian nation into turmoil.

Turnell, a former economic advisor to ousted civilian leader Aung San Suu Kyi, landed in Melbourne early Friday. His wife, Ha Vu, released a statement saying she was “overwhelmed with joy” that her “beloved husband” was back home, Australian network ABC reported.

Earlier, Australian Foreign Minister Penny Wong tweeted a picture of a gaunt-looking Turnell, who had been detained for 650 days, alongside the nation’s diplomatic chief of mission in Myanmar. Turnell had been serving a three-year sentence under the Myanmar Government Secrecy Act.

On Thursday, Myanmar‘s state-run MRTV showed footage of the freed foreign nationals signing exit documents with officials. An announcement posted in state media said the four individuals were released “on humanitarian grounds as well as on the ground of diplomatic relations between Myanmar and their respective countries.”

The British government confirmed the release of Vicky Bowman, a former U.K. ambassador to Myanmar, who had been sentenced to one year for a purported immigration offense. Her Burmese artist husband, Htein Lin, was also pardoned from his one-term prison sentence.

U.S. Secretary of State Antony Blinken, speaking at a news conference Thursday in Bangkok on the sidelines of the APEC summit, welcomed the release of U.S.-Burmese national Kyaw Htay Oo, who he said had been “unjustly detained” and imprisoned in Myanmar for more than 14 months.

The Japanese journalist Kubota, who was arrested in July while filming a protest in Yangon, was serving a 10-year prison term. He arrived back in Tokyo early Friday, Japanese media reported.

2022-11-18T004914Z_769658747_RC20OX9I7ZTQ_RTRMADP_3_MYANMAR-POLITICS-PRISONERS-JAPAN.JPG — Toru Kubota, a Japanese filmmaker freed by authorities in Myanmar, speaks to the media upon his arrival at Haneda Airport, in Tokyo, Japan, Nov. 18, 2022.
CREDIT: Kyodo via Reuters

Junta spokesman Maj. Gen. Zaw Min Tun said Thursday that 5,774 prisoners in all were being released, including 712 political prisoners, to mark Myanmar’s National Victory Day, which commemorates the start of unrest against British colonial rule in 1920.

The state-run Global New Light of Myanmar reported Friday that 985 prisoners, including the four foreigners, were released from Yangon’s Insein Prison, and 485 were released from Mandalay Central Prison.

The newspaper carried a “pardon order” for three prominent opposition figures: former Minister for the Office of the State Counselor Kyaw Tint Swe; former Union Election Commission member Than Htay; and former lawmaker and Tanintharyi Region Chief Minister Lei Lei Maw.

There was also a notice of withdrawal of criminal cases against 11 prominent artists and cultural figures.

Analysts say the amnesty comes as the junta looks to placate the international community, particularly the Southeast Asian bloc, and win support for its plan for elections next year.

The junta, which seized power from an elected civilian administration in February 2021 after the military-backed party fared poorly in national elections, has persecuted its political opponents. Suu Kyi is serving 26 years in prison on what are widely viewed as politically motivated charges. The military takeover has triggered a multi-front insurgency. Local organizations say 1.7 million people have been displaced by the conflict and more than 2,300 civilians have been killed.

The prisoner releases come just as Indonesia takes over the rotating chair of the Association of Southeast Asian Nations. Indonesia was anticipated to take a tougher line toward the junta than the 2022 ASEAN chair, Cambodia, which sent a special envoy to Myanmar twice this year with no progress on implementing the Five Point Consensus, which aimed to restore peace and democracy to the country.